Kentaro Yamazaki

机构：Shizuoka Cancer Center, Tokyo University of Agriculture and Technology · ORCID：0000-0001-6269-9345

发表论文 556 篇 · 总被引 15312 次 · h-index 47

代表论文

• Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial (2025 · Journal of Clinical Oncology · 被引 27)
• Longitudinal ctDNA monitoring and prediction of anti-EGFR rechallenge outcomes in RAS/BRAF wild-type metastatic colorectal cancer (mCRC): The REMARRY & PURSUIT trials. (2025 · Journal of Clinical Oncology · 被引 8)
• Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial (2026 · Nature Medicine · 被引 7)
• Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery (2025 · Annals of Surgery · 被引 5)
• Solvent-based or nab-paclitaxel plus ramucirumab for pretreated gastric cancer with peritoneal dissemination and prespecified biomarker analysis (P-SELECT/WJOG10617G): a randomised phase 2 trial in Japan (2026 · EClinicalMedicine · 被引 4)
• Efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer: a FRESCO-2 subgroup analysis of patients enrolled in Japan (2025 · International Journal of Clinical Oncology · 被引 4)